dragonfly cancer trust limited
dragonfly cancer trust limited Company Information
Company Number
10070362
Website
www.josiesdragonfly.orgRegistered Address
west 2 asama court, west 2, asama court, newcastle upon tyne, tyne and wear, NE4 7YD
Industry
Other social work activities without accommodation n.e.c.
Telephone
01912610971
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
-0%
dragonfly cancer trust limited Estimated Valuation
Pomanda estimates the enterprise value of DRAGONFLY CANCER TRUST LIMITED at £88k based on a Turnover of £157.7k and 0.56x industry multiple (adjusted for size and gross margin).
dragonfly cancer trust limited Estimated Valuation
Pomanda estimates the enterprise value of DRAGONFLY CANCER TRUST LIMITED at £0 based on an EBITDA of £-10.6k and a 4.49x industry multiple (adjusted for size and gross margin).
dragonfly cancer trust limited Estimated Valuation
Pomanda estimates the enterprise value of DRAGONFLY CANCER TRUST LIMITED at £66.5k based on Net Assets of £83.9k and 0.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dragonfly Cancer Trust Limited Overview
Dragonfly Cancer Trust Limited is a live company located in newcastle upon tyne, NE4 7YD with a Companies House number of 10070362. It operates in the other social work activities without accommodation n.e.c. sector, SIC Code 88990. Founded in March 2016, it's largest shareholder is unknown. Dragonfly Cancer Trust Limited is a young, micro sized company, Pomanda has estimated its turnover at £157.7k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dragonfly Cancer Trust Limited Health Check
Pomanda's financial health check has awarded Dragonfly Cancer Trust Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
3 Weak
Size
annual sales of £157.7k, make it smaller than the average company (£432k)
£157.7k - Dragonfly Cancer Trust Limited
£432k - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (4.4%)
11% - Dragonfly Cancer Trust Limited
4.4% - Industry AVG
Production
with a gross margin of 46.9%, this company has a comparable cost of product (46.9%)
46.9% - Dragonfly Cancer Trust Limited
46.9% - Industry AVG
Profitability
an operating margin of -6.8% make it less profitable than the average company (4.6%)
-6.8% - Dragonfly Cancer Trust Limited
4.6% - Industry AVG
Employees
with 3 employees, this is below the industry average (12)
3 - Dragonfly Cancer Trust Limited
12 - Industry AVG
Pay Structure
on an average salary of £25.1k, the company has an equivalent pay structure (£23.3k)
£25.1k - Dragonfly Cancer Trust Limited
£23.3k - Industry AVG
Efficiency
resulting in sales per employee of £52.6k, this is more efficient (£41.4k)
£52.6k - Dragonfly Cancer Trust Limited
£41.4k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Dragonfly Cancer Trust Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Dragonfly Cancer Trust Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Dragonfly Cancer Trust Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1770 weeks, this is more cash available to meet short term requirements (252 weeks)
1770 weeks - Dragonfly Cancer Trust Limited
252 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2.9%, this is a lower level of debt than the average (11.2%)
2.9% - Dragonfly Cancer Trust Limited
11.2% - Industry AVG
DRAGONFLY CANCER TRUST LIMITED financials
Dragonfly Cancer Trust Limited's latest turnover from December 2022 is £157.7 thousand and the company has net assets of £83.9 thousand. According to their latest financial statements, Dragonfly Cancer Trust Limited has 3 employees and maintains cash reserves of £85.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Turnover | 157,683 | 131,677 | 87,905 | 114,033 | 114,952 | 182,619 | 58,417 |
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | -7,749 | 1,391 | -33,215 | -12,632 | -30,178 | -37,231 | -505 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -7,749 | 1,391 | -33,215 | -12,632 | -30,178 | -37,231 | -505 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -7,749 | 1,391 | -33,215 | -12,632 | -30,178 | -37,231 | -505 |
| Employee Costs | 75,308 | 83,951 | 67,722 | 60,446 | 64,054 | 90,633 | 19,445 |
| Number Of Employees | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,048 | 1,233 | 1,451 | 1,707 | 2,008 | 2,368 | 663 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,048 | 1,233 | 1,451 | 1,707 | 2,008 | 2,368 | 663 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 5,192 | 5,150 | 12,970 | 26,473 | 20,177 | 16,475 |
| Cash | 85,408 | 87,317 | 86,785 | 111,032 | 109,887 | 146,284 | 202,634 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 85,408 | 92,509 | 91,935 | 124,002 | 136,360 | 166,461 | 219,109 |
| total assets | 86,456 | 93,742 | 93,386 | 125,709 | 138,368 | 168,829 | 219,772 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 276 | 277 | 277 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 2,509 | 2,046 | 3,081 | 2,189 | 1,941 | 2,223 | 16,440 |
| total current liabilities | 2,509 | 2,046 | 3,081 | 2,189 | 2,217 | 2,500 | 16,717 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 2,509 | 2,046 | 3,081 | 2,189 | 2,217 | 2,500 | 16,717 |
| net assets | 83,947 | 91,696 | 90,305 | 123,520 | 136,151 | 166,329 | 203,055 |
| total shareholders funds | 83,947 | 91,696 | 90,305 | 123,520 | 136,151 | 166,329 | 203,055 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | 185 | 218 | 256 | 301 | 360 | 442 | 24 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -5,192 | 42 | -7,820 | -13,503 | 6,296 | 3,702 | 16,475 |
| Creditors | 0 | 0 | 0 | -276 | -1 | 0 | 277 |
| Accruals and Deferred Income | 463 | -1,035 | 892 | 248 | -282 | -14,217 | 16,440 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | 0 | 0 | 0 | 1 | 0 | 505 | 203,560 |
| cash and cash equivalents | |||||||
| cash | -1,909 | 532 | -24,247 | 1,145 | -36,397 | -56,350 | 202,634 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -1,909 | 532 | -24,247 | 1,145 | -36,397 | -56,350 | 202,634 |
dragonfly cancer trust limited Credit Report and Business Information
Dragonfly Cancer Trust Limited Competitor Analysis
Perform a competitor analysis for dragonfly cancer trust limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in NE4 area or any other competitors across 12 key performance metrics.
dragonfly cancer trust limited Ownership
DRAGONFLY CANCER TRUST LIMITED group structure
Dragonfly Cancer Trust Limited has no subsidiary companies.
Ultimate parent company
DRAGONFLY CANCER TRUST LIMITED
10070362
dragonfly cancer trust limited directors
Dragonfly Cancer Trust Limited currently has 7 directors. The longest serving directors include Mr David Harker (Feb 2021) and Mr Sam Lock (Jul 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr David Harker | England | 61 years | Feb 2021 | - | Director |
| Mr Sam Lock | United Kingdom | 38 years | Jul 2022 | - | Director |
| Mrs Claire Pickersgill | England | 44 years | Nov 2022 | - | Director |
| Mr Ian Lambert | United Kingdom | 40 years | Nov 2023 | - | Director |
| Mr David Gleghorn | United Kingdom | 54 years | Jun 2024 | - | Director |
| Mr Paul Chaytor | United Kingdom | 48 years | Jun 2024 | - | Director |
| Mr Mohammad Bilal | England | 34 years | Aug 2024 | - | Director |
P&L
December 2022turnover
157.7k
+20%
operating profit
-10.8k
0%
gross margin
47%
+0.81%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
83.9k
-0.08%
total assets
86.5k
-0.08%
cash
85.4k
-0.02%
net assets
Total assets minus all liabilities
dragonfly cancer trust limited company details
company number
10070362
Type
Private Ltd By Guarantee w/o Share Cap
industry
88990 - Other social work activities without accommodation n.e.c.
incorporation date
March 2016
age
8
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
josie's dragonfly trust (September 2022)
last accounts submitted
December 2022
address
west 2 asama court, west 2, asama court, newcastle upon tyne, tyne and wear, NE4 7YD
accountant
JOHN H OSWALD
auditor
-
dragonfly cancer trust limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dragonfly cancer trust limited.
dragonfly cancer trust limited Companies House Filings - See Documents
| date | description | view/download |
|---|
